Emory University
Clinical trials sponsored by Emory University, explained in plain language.
-
Hormone therapy explored for brain tumor return
Disease control TerminatedThis early-stage study tested whether natural progesterone, a hormone normally involved in the menstrual cycle, could help control recurrent glioblastoma (a fast-growing brain cancer). Four patients received daily injections of progesterone to see what dose is safe and whether it…
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Promising combo for brain metastases trial halted after just one patient
Symptom relief TerminatedThis early-stage trial aimed to see if adding a device that sends gentle electric fields (tumor treating fields) to standard radiation and immunotherapy could help people with melanoma that spread to the brain. Only one person took part before the study was stopped early. The mai…
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 20, 2026 12:08 UTC
-
Zofran vs. lidocaine: a tiny trial to ease Kids' IV pain
Symptom relief TerminatedThis small study tested whether giving Zofran before propofol (a sleep medicine) could reduce the pain children feel when it's injected through an IV. It compared Zofran to the standard pain reliever lidocaine in 6 children having surgery. The study was stopped early, so results …
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC
-
Which reversal drug gets kids out of the OR quicker?
Symptom relief TerminatedThis study compared two medications, sugammadex and neostigmine, used to reverse muscle relaxants after surgery in children aged 2-17 having their appendix removed. The goal was to see which drug helped children leave the operating room faster and recover bowel function sooner. T…
Phase: PHASE4 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
Sickle cell Drug's brain benefits under the microscope
Knowledge-focused TerminatedThis study looked at whether voxelotor, a drug that improves anemia in sickle cell disease, also helps the brain by improving blood flow and oxygen use. Researchers measured brain activity in children and young adults aged 4 to 30 with sickle cell anemia. The study was stopped ea…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC